Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dover Corp (DOV) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

Dover CorpTrade
Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Dover Corp vs Vaxcyte Inc. Common Stock — how do they compare? Dover Corp trades at $193.04 (market cap $25.92B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Dover Corp is far larger — about 2.5× Vaxcyte Inc. Common Stock's market cap, and Dover Corp pays a 1.09% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dover Corp for 74 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

DOVPCVX
Market Cap
$25.92B$10.51B
Volume
807,4522,644,694
Sector
IndustrialsHealth
52-Week High
$233.31$73.82
52-Week Low
$162.66$40.32
Typical Hold Time
74 Days0 Days
Enterprise Value
$27.43B$9.14B
Dividend Yield
1.09%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dover Corp

Dover Corporation (DOV) trades at $193.33, up 1.28% with strong analyst consensus of 19 Buy ratings and no Sell recommendations. The stock shows solid fundamentals with consistent earnings beats, 13.48% net margin, and robust cash flow. Recent acquisitions and product launches position the company for growth, while technical indicators suggest neutral momentum near key resistance at $195.

Outlook remains positive with 67.9% analyst Buy rating and $243.20 price target representing 26% upside. Risks include integration challenges from recent acquisitions and industrial sector volatility. The company's Dividend King status and strong balance sheet provide stability amid market fluctuations.

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DOV

No sentiment data available yet.

PCVX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Dover Corp

Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.

Read more on DOV →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →